Adaptimmune Therapeutics Plc Overview
Adaptimmune Therapeutics Plc Return on Equity
Return on Equity (ROE) for ADAP.
Get informed when a big investor buys or sells
+ FollowROE
239.23%
Return on Equity
239.23%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Average ROE (Comparison Companies)
ROE History
ROE Comparison